These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30289304)

  • 1. PITUITARY EVALUATION IN PATIENTS WITH LOW PROSTATE-SPECIFIC ANTIGEN.
    Drincic A; Nguyen AT; Singh S; Zena M; Walters R; Friedman K; Anderson RJ
    Endocr Pract; 2018 Dec; 24(12):1030-1037. PubMed ID: 30289304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PITUITARY IMAGING BY MRI AND ITS CORRELATION WITH BIOCHEMICAL PARAMETERS IN THE EVALUATION OF MEN WITH HYPOGONADOTROPIC HYPOGONADISM.
    Das G; Surya A; Okosieme O; Vali A; Tennant BP; Geen J; Abusahmin H
    Endocr Pract; 2019 Sep; 25(9):926-934. PubMed ID: 31170366
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
    Colao A; Spiezia S; Di Somma C; Marzullo P; Cerbone G; Pivonello R; Faggiano A; Lombardi G
    Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
    Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
    J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-to-Testosterone Ratio Predicts Pituitary Abnormalities in Mildly Hyperprolactinemic Men with Symptoms of Hypogonadism.
    Naelitz B; Shah A; Nowacki AS; Bryk DJ; Farber N; Parekh N; Shoskes D; Hatipoglu B; Vij SC
    J Urol; 2021 Mar; 205(3):871-878. PubMed ID: 33080146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men.
    Abbasi AA; Drinka PJ; Mattson DE; Rudman D
    J Am Geriatr Soc; 1993 Sep; 41(9):975-82. PubMed ID: 8409184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP; Gardette J; Rollet J; Legros JJ
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals for important serum sex steroid hormones, prostate-specific antigen, insulin-like growth factor-1 and IGF binding protein-3 concentration in a normal Kuwaiti adult male population.
    Kehinde EO; Akanji AO; Mojiminiyi OA; Al-Awadi KA; Al-Hunayan A; Bashir AA; Abraham MP
    Med Princ Pract; 2005; 14(5):342-8. PubMed ID: 16103701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
    Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
    Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
    Guay AT; Perez JB; Fitaihi WA; Vereb M
    Endocr Pract; 2000; 6(2):132-8. PubMed ID: 11421528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.
    Kim MR; Gupta MK; Travers SH; Rogers DG; Van Lente F; Faiman C
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):203-10. PubMed ID: 10396363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction.
    Corona G; Boddi V; Lotti F; Gacci M; Carini M; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2010 Jan; 7(1 Pt 1):284-92. PubMed ID: 19912506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels.
    Chandrapal JC; Nielson S; Patel DP; Zhang C; Presson AP; Brant WO; Myers JB; Hotaling JM
    BJU Int; 2016 Dec; 118(6):994-1000. PubMed ID: 27226135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of surgical weight loss after sleeve gastrectomy on sex steroids plasma levels and PSA concentration in men with severe obesity.
    Di Vincenzo A; Silvestrin V; Bertoli E; Foletto M; Pagano C; Fabris R; Vettor R; Busetto L; Rossato M
    Aging Male; 2020 Dec; 23(5):464-468. PubMed ID: 30449231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus.
    Dhindsa S; Upadhyay M; Viswanathan P; Howard S; Chaudhuri A; Dandona P
    Endocr Pract; 2008 Nov; 14(8):1000-5. PubMed ID: 19095599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between PSA and Total Testosterone Levels in Men With Prostate Cancer.
    Flores JM; Bernie HL; Miranda E; Nascimento B; Schofield E; Benfante N; Carlsson S; Mulhall JP
    J Sex Med; 2022 Mar; 19(3):471-478. PubMed ID: 35135736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.